Singapore HSA has approved, Astellas Pharma Inc. VYLOY™ (zolbetuximab), an anti-claudin 18.2 (CLDN18.2) monoclonal...
ACRO Biomedical Co. has announced that its ABCcolla Collagen Ophthalmic Matrix has received regulatory ap...
Lucence, a Singaporean precision oncology company, and Hong Kong Precision Oncology Society (HKPOS) are embarking i...
Researchers from the A*STAR Genome Institute of Singapore (A*STAR GIS), together with collaborators from South Korea, Ja...
Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds ...
University of Queensland researchers are designing nanotechnology they believe could improve how we treat the most aggre...
Dr. Shaun Lim Wen Zheng, the Field Application Scientist (APAC) at Cytiva (Left); Krishna Karnati, the General...
The regenerative medicine industry is expanding at an undeniably rapid clip. Advances in cell and gene technologies, tis...
Underscoring the critical role of sleep in diabetes prevention, investigators from the Global Centre for Asian Women&rsq...
Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...
US-based biotech firm Indaptus Therapeutics, Inc. has secured new patent approvals in China, Japan and Israel for its De...
Callio Therapeutics, a Singapore and US-based biotechnology startup focused on realising the promise of multi-payload an...
A peer-reviewed paper detailing the experimental cancer treatment developed by Professor Georgina Long AO, Universi...
Which products are currently under development? 2025 will be a defining year for Caliway as we push ahead with key clin...
Japan-headquartered pharmaceutical firm Eisai has entered into an exclusive license agreement with a subsidiary of SciCl...
US-based startup HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by China-based Harb...
Israel-based CollPlant Biotechnologies, a regenerative and aesthetics medicine company developing innovative technologie...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
